Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.33−0.01 (-4.24%)
Close on Nov 17, 2026Market cap $4.85MP/E –Yield –
Tempest Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Tempest Therapeutics's revenue for the twelve months ending Sep 30, 2018 was $294.00K, down 9.3% year over year. For fiscal 2017 it was $295.00K, down 54.8% from the year before. The highest annual figure on record is $653.00K in fiscal 2016.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $295.00K | -54.8% |
| FY2016 | Dec 31, 2016 | $653.00K | +135.7% |
| FY2015 | Dec 31, 2015 | $277.00K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | $55.00K | -1.8% |
| Q2 FY2018 | Jun 30, 2018 | $81.00K | -3.6% |
| Q1 FY2018 | Mar 31, 2018 | $67.00K | +6.3% |
| Q4 FY2017 | Dec 31, 2017 | $91.00K | -24.8% |
| Q3 FY2017 | Sep 30, 2017 | $56.00K | -71.6% |
| Q2 FY2017 | Jun 30, 2017 | $84.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $63.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $121.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $197.00K | – |
See a number that looks wrong?